Lin, W., Lin, Z., & Zhang, M. (2022). The Therapy of Osimertinib for EGFR Mutation—Non-small Cell Lung Cancer. Highlights in Science, Engineering and Technology, 6, 219-229. https://doi.org/10.54097/hset.v6i.964